UN Warns Gaza Faces Severe Humanitarian Risks Ahead of Winter

Shibbir Ahmed, New York — The United Nations is warning of serious humanitarian and health risks in Gaza as winter approaches, with millions of Palestinians facing inadequate shelter, shortages of essential medical supplies and the growing threat of flooding. The UN World Health Organization (WHO) said on October 2 that repeated delays in bringing lifesaving medicines, prosthetics and other medical supplies into Gaza are putting people in urgent need of care at risk. WHO said almost 2 million people need shelter to protect them from cold weather and flooding, while humanitarian organizations continue to face difficulties bringing winterization and shelter supplies into the territory.

According to the UN Office for the Coordination of Humanitarian Affairs (OCHA), funding shortages and restrictions are severely limiting preparations for the rainy season. A recent OCHA assessment identified 451 displacement sites at high risk of flooding, hosting an estimated 464,402 people. WHO’s representative for the Occupied Palestinian Territory said that, as of October 2, no hospital in Gaza was fully functional, citing chronic shortages of medicines and medical supplies. WHO said large quantities of medical supplies have been waiting for clearance for a median of 74 days, creating significant delays in delivering healthcare assistance.

The UN has called for the unimpeded and predictable entry of humanitarian and health supplies at scale, as well as a system allowing aid to enter through multiple crossings. WHO officials also called for clearer procedures for the approval of humanitarian shipments to reduce delays and rejected consignments. The winter preparations come as Gaza continues to face severe infrastructure and humanitarian challenges. An OCHA report published in September said shortages of cancer medicines, chemotherapy and radiotherapy supplies, dialysis materials, insulin and other essential items were disrupting lifesaving health services.

The UN has also warned that damaged infrastructure and overcrowded displacement sites are increasing the risks associated with heavy rain and flooding. Earlier OCHA reporting said humanitarian efforts to prepare for winter were being constrained by funding shortages, restrictions on supplies entering Gaza and shortages of fuel, engine oil, spare parts and heavy machinery.

A UN report issued in September similarly called for urgent action to restore essential services in Gaza, including electricity, water, sanitation, waste management and healthcare. It described winterization as an urgent priority because shelter needs remain extensive while essential supplies and services remain severely constrained.

The UN’s latest warnings underscore the scale of the challenge facing humanitarian agencies as winter approaches, particularly for displaced families living in damaged buildings, tents and other inadequate shelters.




US Provides 500,000 Dengue Test Kits to Bangladesh

DHAKA — The United States has provided 500,000 dengue NS1 rapid diagnostic test kits to Bangladesh to support the country’s ongoing efforts to detect dengue cases and strengthen treatment management. The kits were provided through the STRIDES programme, funded by the US government, according to a press release. US Chargé d’Affaires to Bangladesh Trishita Maula formally handed over the kits to Health and Family Welfare Minister Sardar Md Sakhawat Husain at Kurmitola Multicare Specialized Hospital in Dhaka on Thursday morning.

Speaking at the handover ceremony, the health minister directed the authorities concerned to distribute the dengue testing kits across the country promptly. He said the ceremony was held at Kurmitola Multicare Specialized Hospital considering traffic congestion and transportation convenience. “However, all the handed-over kits will be deposited directly with the Central Medical Stores Depot (CMSD). Subsequently, the kits will be sent to district and upazila hospitals across the country through the Directorate General of Health Services (DGHS), based on demand,” Sakhawat said. The minister said the government currently has adequate stocks of dengue antigen test kits and intravenous saline in addition to the newly received supplies.

“As a result, the health sector is prepared to ensure necessary testing and treatment even if the number of dengue cases increases in any part of the country,” he said. On the possibility of introducing a dengue vaccine in Bangladesh, Sakhawat said the government was considering the option but stressed the importance of ensuring the vaccine’s efficacy and safety because of its high cost.

“Since the vaccine is costly, it is important to ensure its efficacy and safety,” he said. Discussions are underway with the World Health Organization (WHO), UNICEF and Gavi on the issue, the minister said, adding that a final decision would be taken in line with international guidelines.

Additional Secretary of the Health Services Division Md Rafiqul Islam, Additional Director General of the DGHS Professor Dr Md Zahid Raihan, Director of Kurmitola Multicare Specialized Hospital Brigadier General Md Saydur Rahman, and senior officials from the US Embassy and the Ministry of Health and Family Welfare attended the programme. Later, the minister visited the hospital’s dengue ward and diagnostic laboratory.




Saima Wazed Resigns as WHO Regional Director, Denies Allegations

NEW YORK: Saima Wazed has resigned as the World Health Organization’s (WHO) Regional Director for South-East Asia. According to her resignation letter seen by Reuters, she stepped down amid investigations by the WHO and Bangladeshi authorities into allegations of fraud and document forgery. Her resignation took effect immediately.

Wazed assumed the position of WHO Regional Director for South-East Asia in early 2024 for a five-year term. However, she had been on unpaid administrative leave since July 2025. Earlier, in March 2025, Bangladesh’s Anti-Corruption Commission filed a case against her over allegations of fraud and forgery.

According to the Reuters report, allegations against Wazed included financial irregularities related to a trip to China, providing inaccurate information concerning her educational qualifications, and the alleged illegal acquisition of land in Bangladesh. Wazed has denied the allegations.

A July 3, 2026 letter from her lawyers, seen by Reuters, said the allegation concerning expenses from her China trip did not involve travel fraud. Instead, they said an assistant had made an administrative error while processing the repayment of routine expenses. The amount involved was $901.

Responding to questions about her educational qualifications, Wazed said she had received an honorary doctorate in recognition of her work on autism in Bangladesh and had informed WHO Director-General Tedros Adhanom Ghebreyesus about it.

Regarding the land allegations, Wazed said in her resignation letter that she had acquired the property before joining the WHO. She also said she was entitled to the land under a Bangladeshi law applicable to members of the family of Bangladesh’s founding leader, Sheikh Mujibur Rahman.

In her resignation letter, Wazed further alleged that she had been prevented from effectively carrying out her responsibilities. She said the situation had destroyed her trust and confidence in the WHO leadership. She also said nearly a year without a salary had made her financial situation unsustainable.

The WHO told Reuters that a committee had recommended removing Wazed from her position one day before her resignation. The organization said her resignation would now be considered by the Regional Committee and the Executive Board. A WHO spokesperson said the process had been handled with fairness and appropriate procedures while protecting the organization’s interests and ability to fulfill its responsibilities.

The WHO is preparing to begin the process of selecting Wazed’s successor. Two Reuters sources said nominations are expected to be announced on October 12, applications are expected to be reviewed in December, and the election is planned for January 24. Until a new Regional Director is elected, Dr. Nilesh Buddh will serve in the role.

The Regional Director for WHO’s South-East Asia Region is one of the organization’s key leadership positions. The position involves overseeing the WHO’s response to disease outbreaks and emergencies and helping implement the organization’s policies in accordance with regional circumstances. Member states elect the Regional Director every five years. Bangladesh and India are among the countries in the region.